2 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
Follow Fusilev: new trials by email Literature Review of Fusilev trials Research Report on Fusilev
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn® Folotyn, Fusilev - Non-Small Cell Lung Cancer | Phase 1 | Withdrawn | Acrotech Biopharma Inc. | 2013-04-01 | 2020-01-23 | |
| Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn Fusilev, Folotyn - Non Hodgkin's Lymphoma | Phase 1 | Withdrawn | Acrotech Biopharma Inc. | 2013-03-01 | 2020-01-23 |
Carcinoma, Non-Small-Cell Lung (1) · Lymphoma, Non-Hodgkin (1)
Ahmed Sawas, MD (1)